Sara Carazo

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Daouda Sissoko, Cédric Laouenan, Elin Folkesson et al. · PLoS Medicine · 2016 · 477 citations · Full text

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

Thi Huyen Tram Nguyen, Jérémie Guedj, Xavier Anglaret et al. · PLoS neglected tropical diseases · 2017 · 185 citations · Full text

Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study

Sara Carazo, Danuta M. Skowronski, Marc Brisson et al. · The Lancet Infectious Diseases · 2022 · 121 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)

Danuta M. Skowronski, Yuping Zhan, Samantha E Kaweski et al. · Eurosurveillance · 2024 · 66 citations · Full text

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada

Sara Carazo, Danuta M. Skowronski, Marc Brisson et al. · JAMA Network Open · 2022 · 53 citations · Full text